Evidence map›Paper›PMID 34818345›Full record

ArticlePloS one2021

Bayesian inference across multiple models suggests a strong increase in lethality of COVID-19 in late 2020 in the UK.

Patrick Pietzonka, Erik Brorson, William Bankes, Michael E Cates, Robert L Jack, Ronojoy Adhikari

Abstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Understanding Nash epidemics.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Patrick PietzonkaDAMTP, Centre for Mathematical Sciences, University of Cambridge, Cambridge, United Kingdom.ORCID 0000-0003-1744-3724
Erik BrorsonQuantitative Research, JPMorgan Chase & Co., London, United Kingdom.
William BankesApplied Machine Learning and Artificial Intelligence, JPMorgan Chase & Co., London, United Kingdom.
Michael E CatesDAMTP, Centre for Mathematical Sciences, University of Cambridge, Cambridge, United Kingdom.
Robert L JackDAMTP, Centre for Mathematical Sciences, University of Cambridge, Cambridge, United Kingdom.
Ronojoy AdhikariDAMTP, Centre for Mathematical Sciences, University of Cambridge, Cambridge, United Kingdom.

Funding

European Research Council
6 · The paper itself

Abstract

We apply Bayesian inference methods to a suite of distinct compartmental models of generalised SEIR type, in which diagnosis and quarantine are included via extra compartments. We investigate the evidence for a change in lethality of COVID-19 in late autumn 2020 in the UK, using age-structured, weekly national aggregate data for cases and mortalities. Models that allow a (step-like or graded) change in infection fatality rate (IFR) have consistently higher model evidence than those without. Moreover, they all infer a close to two-fold increase in IFR. This value lies well above most previously available estimates. However, the same models consistently infer that, most probably, the increase in IFR preceded the time window during which variant B.1.1.7 (alpha) became the dominant strain in the UK. Therefore, according to our models, the caseload and mortality data do not offer unequivocal evidence for higher lethality of a new variant. We compare these results for the UK with similar models for Germany and France, which also show increases in inferred IFR during the same period, despite the even later arrival of new variants in those countries. We argue that while the new variant(s) may be one contributing cause of a large increase in IFR in the UK in autumn 2020, other factors, such as seasonality, or pressure on health services, are likely to also have contributed.

Indexed as

Bayes TheoremModels, StatisticalSeverity of Illness IndexCOVID-19HumansPrognosisQuarantineSARS-CoV-2Survival RateUnited Kingdom

Identifiers

PMID34818345
PMCPMC8612566

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.